AARD
NASDAQ · Pharmaceuticals
Aardvark Therapeutics Inc
$3.93
+0.11 (+2.88%)
Open$3.90
Previous Close$3.82
Day High$3.98
Day Low$3.71
52W High$17.94
52W Low$3.35
Volume—
Avg Volume124.0K
Market Cap85.74M
P/E Ratio—
EPS$-3.21
SectorPharmaceuticals
Analyst Ratings
Buy
18 analysts
Price Target
+567.7% upside
Current
$3.93
$3.93
Target
$26.24
$26.24
$21.03
$26.24 avg
$41.18
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 44.31M | 42.19M | 44.45M |
| Net Income | 12.13M | 10.07M | 10.99M |
| Profit Margin | 27.4% | 23.9% | 24.7% |
| EBITDA | 17.61M | 17.80M | 18.44M |
| Free Cash Flow | 9.43M | 7.96M | 8.12M |
| Rev Growth | -1.8% | +11.1% | +14.2% |
| Debt/Equity | 0.60 | 0.62 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,124.85 | +0.68% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $245.14 | +1.72% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $124.71 | +3.41% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $23.83 | -0.87% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.00 | -0.95% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $77.65 | -0.67% | 12.5 | 33.00B |